Olazol, aerosol 80 g

Olazole has an analgesic effect due to the content of anesthesin, disrupts protein synthesis in microorganisms, inhibits their growth and reproduction (levomycetin, boric acid), accelerates epithelization (sea buckthorn oil).

In view of the high dispersion of the ingredients in the product provides a pronounced therapeutic effect. It promotes quick healing of wounds and burns, eliminates pain and ensures painless dressing of patients.

In the first hours and days of application: pain, burning and wound discharge decrease, granulation and epithelialization of the wound edges start. Antibacterial activity against staphylococci, Escherichia coli, Pseudomonas aeruginosa, Proteus and other microorganisms often found in wounds is noted.

Particularly effective for the treatment of sluggish granulation, improves skin flap engraftment in skin grafting on the burn surface. It reduces separation from trophic non-healing ulcers in patients with arterial and venous insufficiency of the lower extremities, promotes clearing of ulcers from purulent-necrotic tissues and accelerates healing.

Indications

Infected wounds (including slow-healing wounds);
trophic ulcers;
burns;
free skin grafting;
microbial eczema;
itchy dermatitis.

Pharmacological effect

Olazol has an analgesic effect due to the content of anesthesin, disrupts protein synthesis in microorganisms, inhibits their growth and reproduction (chloramphenicol, boric acid), accelerates epithelization (sea buckthorn oil).

Due to the high dispersion of the ingredients included in the drug, it provides a pronounced therapeutic effect. Promotes rapid healing of wounds and burns, eliminates pain and ensures painless dressings for patients.

Already in the first hours and days of use: pain, burning and wound discharge decrease, granulation and epithelization of the wound edges begin. Antibacterial activity is noted against staphylococci, Escherichia coli, Pseudomonas aeruginosa, Proteus and other microorganisms often found in wounds.

It is especially effective for the treatment of indolent granulation, improves the survival rate of skin flaps when transplanting skin onto a burn surface. Reduces separation from trophic non-healing ulcers in patients with arterial and venous insufficiency of the lower extremities, helps cleanse ulcers from purulent-necrotic tissue, and accelerates healing.

Active ingredient

Benzocaine, Boric acid, Sea buckthorn fruit oil, Chloramphenicol

Composition

Active ingredients:

sea ​​buckthorn oil 7.2 g;

chloramphenicol 2.16 g;

anesthesin 2.16 g;

boric acid 0.36 g;

triethanolamine 2.16 g;

anhydrous lanolin 0.36 g;

stearic acid 2.88 g;

distilled glycerin 7.2 g;

purified water 47.52 g;

freon-12 8 g;

Contraindications

Hypersensitivity

Side Effects

Allergic reactions.

Interaction

During the treatment period, it is possible to use systemic antibacterial therapy.

Storage conditions

In a dry place, at a temperature not exceeding 15 °C

Shelf life

2 years

Manufacturer

Altaivitamins, Russia